OOIR: Observatory of International Research

Papers

(The TQCC of Thoracic Cancer is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-01-01 to 2025-01-01.)

Article	Citations
Triptolide inhibits esophageal squamous cell carcinoma progression by regulating the circNOX4/miR‐153‐3p/SATB1 signaling pathway	141
	116
Issue Information	102
Rapid and reliable collection of tumor tissue for successful gene panel in a patient with advanced stage lung cancer: A case report	42
Feasibility and safety of secondary video‐assisted thoracoscopic surgery for ipsilateral lung cancer after prior pulmonary resection	33
Pulmonary completion lobectomy after segmentectomy: An integrated analysis of perioperative outcomes	32
Multidimensional profiling depicts infiltrating immune cell heterogeneity in the tumor microenvironment of stage IA non‐small cell lung cancer	32
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China	31
Expectoration of tonsillar metastasis of pulmonary pleomorphic carcinoma after pseudoprogression: A case report	31
Detection of a pinhole‐sized bronchoesophageal fistula under bronchoscopic autofluorescence imaging	30
Dacomitinib as a retreatment for advanced non‐small cell lung cancer patient with an uncommon EGFR mutation	30
Issue Information	28
Tracheal polypoid combined small cell lung cancer (C‐SCLC): A case report	26
Premature phase II study of amrubicin as palliative chemotherapy for previously treated malignant pleural mesothelioma	26
	24
Ruptured pseudoaneurysm of the thoracic aorta mimicking lung cancer: A case report	24
Using the neutrophil‐to‐lymphocyte ratio to predict the outcome of individuals with nonsquamous non‐small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed	24
	24
Issue Information	24
Age‐related features of lung cancer treatment using reprogrammed CD8 positive T cells in mice subjected to injection of Lewis lung carcinoma cells	23
Primary ciliated muconodular papillary tumor: A rare pulmonary disease and literature review of 65 cases	23
	23
Afatinib and osimertinib in lung adenocarcinoma harbored EGFR T751_I759delinsS mutation: A case report	23
Enhanced prediction of postoperative radiotherapy‐induced esophagitis in non‐small cell lung cancer: Dosiomic model development in a real‐world cohort and validation in the PORT‐C randomize	22
Relationship between the combination of platelet count and neutrophil‐lymphocyte ratio and prognosis of patients with advanced non‐small cell lung cancer treated with immune checkpoint inhibitors plus	22

Construction of a nomogram model based on biomarkers for liver metastasis in non‐small cell lung cancer	22
Immune‐inflammatory markers and clinical characteristics as predictors of the depth of response and prognosis of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer re	22
Comparison of next‐generation sequencing and cobas EGFR mutation test v2 in detecting EGFR mutations	21
Rapidly developing intrathoracic low‐grade fibromyxoid sarcoma: A case report	21
A rare case of docetaxel‐induced myositis in a patient with a lung adenocarcinoma	21
Efficacy and safety of bevacizumab combined with EGFR‐TKIs in advanced non‐small cell lung cancer: A meta‐analysis	21
Lymph node metastasis and its risk factors in T1 lung adenocarcinoma	20
Issue Information	20
First report of an adult female patient with endobronchial inflammatory myofibroblastic tumor in Taiwan: A case report	19
Enhancing precision in lung tumor ablation through innovations in CT‐guided technique and angle control	19
Stereotactic ablative radiotherapy as single treatment for early stage non‐small cell lung cancer: A single institution analysis	19
Prognostic, immunity, stemness, and anticancer drug sensitivity characterization of pyroptosis related genes in non‐small cell lung cancer	19
Whole‐exome sequencing in primary pulmonary synovial sarcoma misdiagnosed as mesothelioma: A case report and literature review	18
LINC02323 facilitates development of lung squamous cell carcinoma by miRNA sponge and RBP dysregulation and links to poor prognosis	18
Issue Information	18
Exceptionally long‐lasting response to dabrafenib plus trametinib treatment in a patient with lung adenocarcinoma harboring the BRAF V600E mutation with high expression of PD‐L1	18
Safety of anti‐SARS‐CoV‐2 messenger RNA vaccine in lung cancer patients undergoing anticancer chemotherapy: A multicenter, prospective, observational, patient‐reported	17
Real‐world treatment and prognostic factors for survival in ALK+ non‐small cell lung cancer (NSCLC) patients with brain metastases in China	17
Issue Information	17
Non‐small cell lung cancer with EGFR (L858R and E709X) and CNNB1 mutations responded to afatinib	17
Identification and validation of the model consisting of DDX49, EGFR, and T‐stage as a possible risk factor for lymph node metastasis in patients with lung cancer	17
Issue Information	17
Issue Information	17
Co‐occurring KEAP1 and TP53 mutations in lung squamous cell carcinoma induced primary resistance to thoracic radiotherapy: A case report	17
Is response evaluation criteria in solid tumors (RECIST) effective in patient selection for radical resection after neoadjuvant immunotherapy with advanced NSCLC?	17
Correlations between class I glucose transporter expression patterns and clinical outcomes in non‐small cell lung cancer	16
Chest computed‐tomography 1 day before the diagnosis of coronavirus disease 2019	16
Comprehensive expressional analysis of chemosensitivity‐related markers in large cell neuroendocrine carcinoma of the lung	15
Issue Information	15
Life‐threatening extrapleural hematoma in an anticoagulated patient 2 weeks after lobectomy	15
	15
	15
Issue Information	14
Using a risk model for probability of cancer in pulmonary nodules	14
Electromagnetic navigational bronchoscopy‐guided dye marking to identify the subsegmental bronchus in thoracoscopic anatomic subsegmentectomy	14
Pulmonary artery occlusion post immunotherapy for hilar node‐positive lung cancer	14
Impact of tumor size and location on lung dose difference between stereotactic body radiation therapy techniques for non‐small cell lung cancer	14
Could intracranial tumor volume predict prognosis of patients with brain metastases from esophageal carcinoma?	14
Successful treatment of refractory brain metastases from ALK‐positive lung cancer with lorlatinib	14
Radiation therapy induces an abscopal effect and upregulates programmed death‐ligand 1 expression in a patient with non‐small cell lung cancer	14
Mediastinal undifferentiated pleomorphic sarcoma with pleural effusion cytopathologically misdiagnosed as epithelial malignant pleural mesothelioma: An autopsy case report	14
Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell‐derived organoids	14
Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non‐small‐cell lung cancer	14
Predicting prognosis using a pathological tumor cell proportion in stage I lung adenocarcinoma	14
	14
Gastroesophageal reflux disease and paraneoplastic neurological syndrome associated with long‐term survival in limited stage small‐cell lung cancer	14
Identification of predictive factors for early relapse in patients with unresectable stage III non‐small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation	14
Endobronchial brachytherapy combined with surgical procedure for synchronous multiple primary lung cancer: A case report	14
Correction to “Clinical benefit of platinum doublet combination therapy in older adults with advanced non‐small cell lung cancer: A prospective multicenter study by the National Hospital Organization	14
One‐way endobronchial valves in the management of complex persistent air leaks in a soft tissue sarcoma patient	14

Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report	14
Immunotherapy combined with chemotherapy versus chemotherapy alone as the first‐line treatment of PD‐L1‐negative and driver‐gene‐negative advanced nonsquamous non‐small‐cell lung cancer: An	13
Response to ALK‐TKIs in a lung adenocarcinoma patient harboring dual DCTN1‐ALK and ALK‐CLIP4 rearrangements	13
Dysbiosis of lower respiratory tract microbiome are associated with proinflammatory states in non‐small cell lung cancer patients	13
A randomized phase II study of docetaxel or pemetrexed with or without the continuation of gefitinib after disease progression in elderly patients with non‐small cell lung cancer harboring	13
Reporting quality of randomized, controlled trials evaluating immunotherapy in lung cancer	13
Immunotherapy plus chemotherapy showed superior clinical benefit to chemotherapy alone in advanced NSCLC patients after progression on osimertinib	13
Malignant transformation of heterotopic pancreas as middle esophagus adenocarcinoma—A rare case report and comprehensive literature review	13
Issue Information	13
Serum miR‐205‐5p level for non–small‐cell lung cancer diagnosis	13
Icotinib alone or with bevacizumab as first‐line therapy in Chinese patients with advanced nonsquamous non‐small cell lung cancer and activating EGFR mutations: A retrospective study	13
Significant difference in recurrence according to the proportion of high grade patterns in stage IA lung adenocarcinoma	13
A phase II study of anlotinib combined with etoposide and platinum‐based regimens in the first‐line treatment of extensive‐stage small cell lung cancer	13
Focal ¹⁸F‐FDG uptake predicts progression of pre‐invasive squamous bronchial lesions to invasive cancers	12
KIAA1429 regulates lung adenocarcinoma proliferation and metastasis through the PI3K/AKT pathway by modulating ARHGAP30 expression	12
Predicting pathological response to neoadjuvant or conversion chemoimmunotherapy in stage IB–III non‐small cell lung cancer patients using radiomic features	12
Impact of the combination of sintilimab and chemotherapy on the tumor and paratumor PD‐L1, IDO, TIM‐3, FOXP3+ and CD8 expressions in patients wit	12
Left sleeve pneumonectomy via uniportal video‐assisted thoracoscopic approach	12
Enhanced systemic antitumor efficacy of PD‐1/PD‐L1 blockade with immunological response induced by photodynamic therapy	12
AMPAR receptor inhibitors suppress proliferation of human small cell lung cancer cell lines	12
	12
Successful immune checkpoint inhibitor‐based rechallenge in a patient with advanced esophageal squamous cell cancer: A case report	12
How to distinguish thoracic and cervical lymph nodes during minimally invasive esophagectomy	12
	12
Thoracic myopericytoma in an older adult, rare but possible: A case report	12
Issue Information	12
A rare presentation of anaplastic large cell lymphoma as a cavitary pulmonary mass with hypercalcemia	11
An extremely rare case of pulmonary epithelioid hemangioendothelioma	11
Prognostic factors and survival outcome of primary pulmonary acinar cell carcinoma	11
Comparison of perioperative and survival outcomes between sublobar resection and lobectomy of patients who underwent a second pulmonary resection	11
The role of microbiota in esophageal squamous cell carcinoma: A review of the literature	11
Heterogeneity or transformation? A whack‐a‐mole case of EGFR‐mutant lung adenocarcinoma and small cell carcinoma: A case report	11
Adiponectin‐expressing Treg‐containing T cell fraction inhibits tumor growth in orthotopically implanted triple‐negative breast cancer	11
Issue Information	11
Evidence for marked underutilization of insurance billing in malignant pleural mesothelioma in Finland	11
Locally advanced primary mediastinal atypical carcinoid successfully resected after neoadjuvant treatment: A case report	11
Efficacy and safety of 3 mg pegylated recombinant human granulocyte colony‐stimulating factor as support to chemotherapy for lung cancer	11
A novel form of precise segmentectomy—Triumphal arch‐like anatomical segmentectomy	11
Endotracheal enucleation and para‐toluenesulfonamide injection for adenoid cystic carcinoma in the upper trachea: A novel therapeutic approach	11
Treatment of advanced lung cancer based on genomic profiling using liquid biopsy (plasma): A review of three cases	11
	11
Longitudinal changes in skeletal muscle mass in patients with advanced squamous cell lung cancer	10
Two‐stage minimally invasive pulmonary resections with intraoperative localization technique for bilateral multiple primary lung cancers: A case report	10
Real‐world treatment patterns and clinical outcomes after introduction of immune checkpoint inhibitors: Results from a retrospective chart review of patients with advanced/metastatic non‐small cell lu	10
Large pulmonary sclerosing pneumocytoma in a young female: A rare lung tumor	10
Angiosarcoma of breast and chest wall complicated with tuberculous empyema: A case report	10
Clinical definition of secondary resistance to immunotherapy in non‐small cell lung cancer	10
Evaluation of pain levels treated by the distal end of the hook‐wire positioning needle: A randomized controlled study	10
2024 multidisciplinary consensus on image‐guided lung tumor ablation from the Taiwan Academy of Tumor Ablation	10
The reversal of drug resistance by two‐dimensional titanium carbide Ti₂C (2D Ti2C) in non‐small‐cell lung cancer via the depletion of intracellular antioxidant reserves	10
Surgical treatment for lung metastasis of inflammatory myofibroblastic tumor of the lung: A case report	10
	10
Clinical characteristics of patients with KRAS mutation detected by liquid biopsy	10
Epicardial carvernous hemangioma: The diagnostic challenge of a middle mediastinal mass	10
The survival after discontinuation of EGFR‐TKIs due to intolerable adverse events in patients with EGFR‐mutated non–small cell lung cancer	10
Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report	10
Diagnosis of miliary nodules as lung adenocarcinoma by cryobiopsy: A case report	10
Combined minimally invasive resection of thoracic neurogenic dumbbell tumors: A European case series	10
Pulmonary mucoepidermoid carcinoma: A clinicopathological study of 45 patients	10
Long‐term follow‐up of unresectable adenoid cystic carcinoma of the trachea and bronchus treated with high‐dose proton beam therapy: A report of two cases	10
	10
Significance of tumor mutation burden and immune infiltration in thymic epithelial tumors	10
Use of PD‐1 inhibitor tislelizumab in the treatment of advanced pulmonary sarcomatoid carcinoma: A case report	10
Survival benefits from afatinib compared with gefitinib and erlotinib among patients with common EGFR mutation in first‐line setting	10
Programmed death‐ligand 1 expression and use of immune checkpoint inhibitors among patients with advanced non‐small‐cell lung cancer in a resource‐limited country	10
Association of optic nerve sheath lesion and brain or meningeal metastasis caused by lung cancer	10
Surgical outcomes for non‐small cell lung cancer in younger adults: A population‐based study	9
Circ_0002476 regulates cell growth, invasion, and mtDNA damage in non–small cell lung cancer by targeting miR‐1182/TFAM axis	9
Treatment with immune checkpoint inhibitors after EGFR‐TKIs in EGFR‐mutated lung cancer	9
Circ‐PITX1 promotes non‐small‐cell lung cancer progression through regulating ETS1 expression via miR‐615‐5p	9
Is using a consolidation tumor ratio 0.5 as criterion feasible in daily practice? Evaluation of interobserver measurement variability of consolidation tumor ratio of lung cancer less than 3 cm in size	9
Are more courses of immunochemotherapy beneficial for the short‐term outcome of locally advanced esophageal squamous cell carcinoma?	9
	9
Prediction performance comparison of biomarkers for response to immune checkpoint inhibitors in advanced non‐small cell lung cancer	9
Issue Information	9
Establishment and characterization of a novel highly malignant lung cancer cell line ZX2021H derived from a metastatic lymph node lesion	9
Left pulmonary vein anatomical variation in Turner syndrome. Benefits of three‐dimensional visualization for surgical planning	9
Thoracic skeletal muscle mass predicts mortality in patients with surgery for pleural empyema: A case control study	9
Capmatinib successfully overcomes tepotinib‐induced intolerable peripheral edema	9
Effect of ultrasound‐guided thoracic paravertebral block on perioperative analgesia in elderly patients undergoing video‐assisted thoracic lobectomy in China: An interventional clinical randomized con	9

Issue Information	9
Aspergillus ball crawling out of pulmonary bullae	9
Issue Information	9
Adjuvant chemotherapy in node‐positive patients after esophagectomy for esophageal squamous cell carcinoma	9
Safety and efficacy of endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA) for patients aged 80 years and older	9
Comparative efficacy of immune checkpoint inhibitors versus chemotherapy alone in diffuse pleural mesothelioma	9
Noninvasive assessment of breast cancer molecular subtypes on multiparametric MRI using convolutional neural network with transfer learning	9
Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second‐line chemotherapy in patients with small cell lung cancer	9
MiR‐671‐5p sponging activity of circMMP1 promotes esophageal squamous cancer progression	9
Exosomal GPT2 derived from triple‐negative breast cancer cells promotes metastasis by activating BTRC	9
Risks of segmentectomy for interstitial pneumonia with diffuse pulmonary ossification	9
Combined targeting of EGFR and BRAF triggers regression of osimertinib resistance by using osimertinib and vemurafenib concurrently in a patient with heterogeneity between differ	9
Effect of perioperative aspirin continuation on bleeding after pneumonectomy	9
	9
Sevoflurane suppresses the malignant progression of breast cancer via the hsa_circ_0000129/miR‐578/EPSTI1 axis	9
A prognostic classification based on the International Association for the Study of Lung Cancer histologic grading and immunoscore in KRAS‐mutant invasive non‐mucinous adenocarcinoma	9
Improved survival in patients with isolated liver metastasis at initial diagnosis with surgery at primary and metastatic sites: A population‐based study in patients with breast cancer	9
Computed tomography‐based radiomics and clinical‐genetic features for brain metastasis prediction in patients with stage III/IV epidermal growth factor receptor‐mutant non‐small‐	9
The airway microbiota of non‐small cell lung cancer patients and its relationship to tumor stage andEGFRgene mutation	8
Clinical characteristics of myasthenia gravis (MG) patients developing other autoimmune diseases after thymectomy from one single center cohort	8
Intratumoral genetic and immune microenvironmental heterogeneity in T4N0M0 (diameter ≥ 7 cm) non‐small cell lung cancers	8
Pharmacokinetics of alectinib and its metabolite M4 in a patient with advanced lung adenocarcinoma undergoing hemodialysis: A case report	8
Salidroside suppresses the multiple oncogenic activates and immune escape of lung adenocarcinoma through the circ_0009624‐mediated PD‐L1 pathway	8
Survival outcomes of east Asian patients with advanced non‐small cell lung cancer treated with first‐line EGFR tyrosine kinase inhibitors: A network meta‐analysis of real‐world evidence	8
Disease control in patients with non‐small cell lung cancer using pemetrexed: Investigating the best treatment strategy	8
Prognostic factors for survival in extensive‐stage small cell lung cancer: An Italian real‐world retrospective analysis of 244 patients treated over the last decade	8
Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran (BNT162b2, Pfizer‐BioNTech)	8
Successful restart of chemotherapy in a patient with primary mediastinal nonseminomatous germ cell tumor after COVID‐19 infection	8
Relationship between immune‐related adverse events and treatment effectiveness in extensive disease small cell lung cancer	8
Pathological characteristics of lung tumors in Sri Lanka 2017–2021	8
Pericancerous lymph node imaging with indocyanine green‐guided near‐infrared fluorescence in radical esophagectomy: Protocol for a single‐center, prospective, randomized controlled clinical trial	8
Recurrent esophageal adenocarcinoma derived from ectopic gastric mucosa: A case report	8
Genomic analysis between idiopathic pulmonary fibrosis and associated lung cancer using laser‐assisted microdissection: A case report	8
Evaluation of appropriate conditions for Oncomine DxTT testing of FFPE specimens for driver gene alterations in non–small cell lung cancer	8
Pseudocirrhosis due to liver metastasis from lung adenocarcinoma	8
Chinese expert consensus on the diagnosis and treatment of HER2‐altered non–small cell lung cancer	8
Circulating microRNAs as indicators in the prediction of neoadjuvant chemotherapy response in luminal B breast cancer	8
N⁶‐methyladenosine‐modified circFUT8 competitively interacts with YTHDF2 and miR‐186‐5p to stabilize FUT8 mRNA to promote malig	8
Multi‐center experience in an optimized right upper lobectomy surgical procedure in China	8
Disease monitoring of epidermal growth factor receptor (EGFR)‐mutated non‐small‐cell lung cancer patients treated with tyrosine kinase inhibitors via EGFR status in circulating tumor D	8
Diagnostic efficacy of sentinel lymph node in breast cancer under percutaneous contrast‐enhanced ultrasound: An updated meta‐analysis	8
Symptom trajectories during chemotherapy in patients with non‐small cell lung cancer (NSCLC) and the function of prolonging low dose dexamethasone in promoting enhanced recovery	8
Lung adenocarcinoma with micropapillary and solid patterns: Recurrence rate and trends	8
The role of spleen radiomics model for predicting prognosis in esophageal squamous cell carcinoma patients receiving definitive radiotherapy	8
Exploratory analysis to predict pneumonitis during durvalumab consolidation therapy for patients with locally advanced non‐small cell lung cancer from proteomic profiling of circulating extracellular	8
	8
Comparison of primary and metastatic site‐related PD‐L1 expression in predicting ORR in patients with advanced NSCLC who received ICB‐based therapy	8
Dosimetric comparison of five different radiotherapy treatment planning approaches for locally advanced non‐small cell lung cancer with sequential plan changes	8
Cetuximab enhances radiosensitivity of esophageal squamous cell carcinoma cells by G2/M cycle arrest and DNA repair delay through inhibiting p‐EGFR and p‐ERK	8
	8
Clinical characteristics of paraneoplastic neurological syndrome related to different pathological lung cancers	8
Uniportal video‐assisted thoracoscopic left pneumonectomy: Retrospective analysis of eighteen consecutive patients from a single center	8
Clinical efficacy of amrubicin in patients with small cell lung cancer relapse after first‐line treatment including immune checkpoint inhibitors: A retrospective multicenter study (TOPGAN 2	8
Apatinib as maintenance therapy following standard first‐line chemotherapy in extensive disease small cell lung cancer: A phase II single‐arm trial	8
IgG4‐related retroperitoneal fibrosis induced by nivolumab and ipilimumab in a patient with non‐small cell lung cancer: A case report	8
Relapse predictability of topological signature on pretreatment planning CT images of stage I non‐small cell lung cancer patients before treatment with stereotactic ablative radiotherapy	8
Efficacy of paclitaxel‐carboplatin with bevacizumab as a late‐line therapy for patients with advanced nonsquamous non‐small cell lung cancer: A platinum rechallenge	8
Station 3A lymph node dissection does not improve long‐term survival in right‐side operable non‐small‐cell lung cancer patients: A propensity score matching	8
Issue Information	8
Operative outcomes and long‐term survival of patients undergoing colon interposition after esophagectomy for cancer	8
Challenges of the eighth edition of the American Joint Committee on Cancer staging system for pathologists focusing on early stage lung adenocarcinoma	8
Extended ICI treatment after first‐line chemoimmunotherapy could predict the clinical benefit of ramucirumab plus docetaxel in advanced non‐small lung cancer: Post hoc analysis from NE	8
Clinical utility of the C‐reactive protein:albumin ratio in non‐small cell lung cancer patients treated with nivolumab	8
Issue Information	8
Diabetic ketoacidosis shortly after COVID‐19 vaccination in a non–small‐cell lung cancer patient receiving combination of PD‐1 and CTLA‐4 inhibitors: A case report	8
Thoracic SMARCA4‐deficient undifferentiated tumor diagnosed by transbronchial mediastinal cryobiopsy: A case report	8
Gene‐level dissection of chromosome 3q locus amplification in squamous cell carcinoma of the lung using the nCounter assay	8
Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer	8
Correction to “Circ‐PDZD8 promotes cell growth and glutamine metabolism in non‐small cell lung cancer by enriching LARP1 via sequestering miR‐330‐5p”	8
Diagnostic challenge and survival analysis of pulmonary oligometastases and primary lung cancer in breast cancer patients	8
Prognostic value of the geriatric nutritional risk index among patients with previously treated advanced non‐small cell lung cancer who subsequently underwent immunotherapy	8
The efficacy of almonertinib and anlotinib combination therapy for advanced non‐small‐cell lung cancer patients who continued to experience cancer progression during third‐generation EGFR‐TKI	8
Chemoradiation followed by adjuvant durvalumab in stage III non–small cell lung cancer: Real‐world comparison of treatment outcomes to historical controls treated with chemoradia	8
An easy tool to predict survival in patients with bone metastatic lung cancer treated with palliative radiotherapy	7
Esophageal submucosal tumor diagnosed with EBUS‐guided transbronchial mediastinal cryobiopsy: A case report	7
Secular trends of morbidity and mortality of thyroid cancer in five Asian countries from 1990 to 2019 and their predictions to 2035	7
Prognostic value of ferroptosis‐related genes in patients with lung adenocarcinoma	7
Safety and efficacy of microwave ablation for lung cancer adjacent to the interlobar fissure	7
Clinical case of lung spindle cell carcinoma markedly responsive to pembrolizumab	7
Differential diagnosis of lung cancer and benign lung lesion using salivary metabolites: A preliminary study	7
Prevalence and management of pain in lung cancer patients in northern China: A multicenter cross‐sectional study	7
Clinical characteristics and prognostic impact of acute exacerbations in patients with interstitial lung disease and lung cancer: A single‐center, retrospective cohort study	7
Predicting the efficacy of first‐line immunotherapy by combining cancer cachexia and tumor burden in advanced non‐small cell lung cancer	7
Elevated neutrophil‐to‐lymphocyte ratio (NLR) is associated with poorer progression‐free survival in unresectable stage III NSCLC treated with consolidation durvalumab	7
Study protocol: A single‐arm, multicenter, phase II trial of camrelizumab plus apatinib for advanced nonsquamous NSCLC previously treated with first‐line immunotherapy	7
Immune checkpoint inhibitors for first‐line treatment of advanced non‐small‐cell lung cancer: A systematic review and network meta‐analysis	7
Relationship between the severity of emphysematous change in the lung and morbidity after esophagectomy for esophageal cancer: A retrospective study on a novel strategy for risk prediction	7
Randomized phase 2 study comparing irinotecan versus amrubicin as maintenance therapy after first‐line induction therapy for extensive disease small cell lung cancer (HOT1401/NJLCG1401	7
NLR, MLR, and PLR are adverse prognostic variables for sleeve lobectomy within non‐small cell lung cancer	7
Transformation or tumor heterogeneity: Mutations in EGFR, SOX2, TP53, and RB1 persist in the histological rapid conversion from lung adenocarcinoma to small	7
Second‐line lurbinectedin as a new treatment option for small‐cell lung cancer: Preliminary results in real‐clinical practice	7
Real‐world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non‐small cell lung cancer	7
Clinical outcomes of EGFR+/METamp+ vs. EGFR+/METamp‐ untreated patients with advanced non‐small cell lung cancer	7
Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows	7
Observed and relative survival trends of lung cancer: A systematic review of population‐based cancer registration data	7